University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

Medically reviewed by Adam M. Brufsky, MD, PhD The exact cause or causes of triple-negative breast cancer are unknown, but ...

Researchers at the Markey Cancer Center have made an important discovery that could lead to new treatments for ...

University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

There isn't enough evidence to support the use of Merck & Co/MSD's Keytruda in combination with chemotherapy as a first-line treatment for advanced triple negative breast cancer, according to the ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

Triple negative breast cancer is an aggressive type of breast cancer that carries a higher risk of recurrence and death after standard treatment. As such, there is an urgent need for more ...

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

UT Southwestern clinical trials published in the Journal of Clinical Oncology found a far shorter, simpler, and less toxic treatment protocol for patients with triple-negative breast cancer (TNBC ...

Triple-negative breast cancer (TNBC), a subgroup that lacks expression of hormone receptors and HER2, overlaps with basal-like breast cancer (BLBC), a subgroup that expresses cytokeratins and ...

Dongan Hills resident Melissa Hickey turned her chemotherapy sessions into carnivals, movie sets and tea parties.